asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female aged 18 to 70 years old; 2. Outpatients, have physician diagnosed asthma or have asthma symptoms; 3. Patients with diagnosed mild-to-moderate persistent asthma of severity level 2-3; 4. Agree and sign written consent form.
Exclusion criteria
Exclusion criteria: 1. Investigational drug use in the previous 1 month; 2. Use of systemic corticosteroids in the previous 1 month; 3. General infection, lower respiratory tract infection, tuberculosis, fungal infection in the previous 1 month; 4. Severe asthma exacerbation 3 months prior to entry or within run-in period; 5. Change regular asthma treatment within the previous 3 months; 6. Have conditions that have to receive sodium cromoglycate, theophylline, leukotriene antagonists or anticholinergic agents; 7. Have a history of allergy to any of the Salmeterol/Fluticasone ingredients; 8. Serious comorbidities such as hypertension, cancer, cardiovascular disease, liver, kidney and hematopoietic system disease; 9. Combined conditions such as wheezing caused by tuberculosis, bronchiectasis and cardiac insufficiency; 10. Patients with hyperthyroidism; 11. Have psychiatric disorder or acrasia, can not speak clearly; 12. Being pregnant, during lactation or planning for pregnancy during the current study; 13. Any significant disorder that in the investigators opinion, might put patient at risk or influence study outcomes; 14. Have acupuncture contraindications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent of symptom-free days;asthma control test scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| lung function;counts of EOS in blood;Immunological indicators; | — |
Countries
China
Contacts
Gumei Community Health Center ofMinhang district, Shanghai, China